Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Vaccines and Antiviral Agents | Spotlight

GSK3732394: a Multi-specific Inhibitor of HIV Entry

David Wensel, Yongnian Sun, Jonathan Davis, Zhufang Li, Sharon Zhang, Thomas McDonagh, David Langley, Tracy Mitchell, Sebastien Tabruyn, Patrick Nef, Mark Cockett, Mark Krystal
Viviana Simon, Editor
David Wensel
aViiV Healthcare, Branford, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongnian Sun
bBristol-Myers Squibb, Wallingford, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Davis
cBristol-Myers Squibb, Waltham, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhufang Li
aViiV Healthcare, Branford, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Zhang
aViiV Healthcare, Branford, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas McDonagh
cBristol-Myers Squibb, Waltham, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Langley
bBristol-Myers Squibb, Wallingford, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tracy Mitchell
cBristol-Myers Squibb, Waltham, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastien Tabruyn
dTransCure bioServices, Archamps, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Nef
dTransCure bioServices, Archamps, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Cockett
aViiV Healthcare, Branford, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Krystal
aViiV Healthcare, Branford, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viviana Simon
Icahn School of Medicine at Mount Sinai
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.00907-19
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1128/JVI.00907-19
PubMed 
31375580

Published By 
American Society for Microbiology Journals
History 
  • Received May 29, 2019
  • Accepted July 19, 2019
  • Published online September 30, 2019.

Copyright & Usage 
Copyright © 2019 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers 
  • Viviana Simon, Editor, Icahn School of Medicine at Mount Sinai

Article Versions

  • Accepted Manuscript version (August 02, 2019).
  • You are viewing the most recent version of this article.

Author Information

  1. David Wensela,
  2. Yongnian Sunb,
  3. Jonathan Davisc,
  4. Zhufang Lia,
  5. Sharon Zhanga,
  6. Thomas McDonaghc,
  7. David Langleyb,
  8. Tracy Mitchellc,
  9. Sebastien Tabruynd,
  10. Patrick Nefd,
  11. Mark Cocketta and
  12. Mark Krystala
  1. aViiV Healthcare, Branford, Connecticut, USA
  2. bBristol-Myers Squibb, Wallingford, Connecticut, USA
  3. cBristol-Myers Squibb, Waltham, Massachusetts, USA
  4. dTransCure bioServices, Archamps, France
  • Address correspondence to Mark Krystal, Mark.R.Krystal{at}viivhealthcare.com.
  • Citation Wensel D, Sun Y, Davis J, Li Z, Zhang S, McDonagh T, Langley D, Mitchell T, Tabruyn S, Nef P, Cockett M, Krystal M. 2019. GSK3732394: a multi-specific inhibitor of HIV entry. J Virol 93:e00907-19. https://doi.org/10.1128/JVI.00907-19.

View Abstract

Article usage

Article usage: July 2019 to January 2021

Rendering graph...
AbstractFullPdf
Jul 2019101
Aug 2019460069
Sep 20193892243
Oct 2019431131107
Nov 2019922323
Dec 2019821324
Jan 2020842239
Feb 2020581343
Mar 2020552036
Apr 202054145
May 202034935
Jun 202024265
Jul 202024354
Aug 202002721
Sep 202003324
Oct 202042624
Nov 202042428
Dec 202073123
Jan 202132935
PreviousNext
Back to top
Download PDF
Citation Tools
GSK3732394: a Multi-specific Inhibitor of HIV Entry
David Wensel, Yongnian Sun, Jonathan Davis, Zhufang Li, Sharon Zhang, Thomas McDonagh, David Langley, Tracy Mitchell, Sebastien Tabruyn, Patrick Nef, Mark Cockett, Mark Krystal
Journal of Virology Sep 2019, 93 (20) e00907-19; DOI: 10.1128/JVI.00907-19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
GSK3732394: a Multi-specific Inhibitor of HIV Entry
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
GSK3732394: a Multi-specific Inhibitor of HIV Entry
David Wensel, Yongnian Sun, Jonathan Davis, Zhufang Li, Sharon Zhang, Thomas McDonagh, David Langley, Tracy Mitchell, Sebastien Tabruyn, Patrick Nef, Mark Cockett, Mark Krystal
Journal of Virology Sep 2019, 93 (20) e00907-19; DOI: 10.1128/JVI.00907-19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

CD4
HIV entry
adnectins
gp41
inhibitor
synergy

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514